|
|
|
|
| LEADER |
01119naa a2200325 i 4500 |
| 001 |
NSK01000957116 |
| 003 |
HR-ZaNSK |
| 005 |
20170331110550.0 |
| 007 |
ta |
| 008 |
170228s2014 ci | |0|| ||eng |
| 035 |
|
|
|a (HR-ZaNSK)000957116
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a eng
|b hrv
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 616
|2 MRF 2011.
|
| 080 |
1 |
|
|a 615
|2 MRF 2011.
|
| 100 |
1 |
|
|a Vazdar, Ljubica
|
| 245 |
1 |
0 |
|a Timing of trastuzumab and risk of cardiac dysfunction in HER2 positive early breast cancer patients /
|c Ljubica Vazdar, Mirjana Pavlović, Robert Šeparović, Tajana Silovski, Ivo Darko Gabrić.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 18 jed.
|
| 504 |
|
|
|a Sažetak
|
| 653 |
|
0 |
|a Karcinom dojke
|a Trastuzumab
|a Zatajenje srca
|a Adjuvantna kemoterapija
|a Antraciklini
|
| 700 |
1 |
|
|a Pavlović, Mirjana,
|c liječnica
|
| 700 |
1 |
|
|a Šeparović, Robert
|
| 700 |
1 |
|
|a Stančerić, Tajana
|
| 700 |
1 |
|
|a Gabrić, Ivo Darko
|
| 773 |
0 |
|
|t Libri oncologici
|x 0300-8142
|g 42 (2014), 1/3 ; str. 93-97
|w nsk.(HR-ZaNSK)000011357
|
| 981 |
|
|
|b B11/14
|
| 998 |
|
|
|a sapo1702
|